Advertisement
Screener

United Therapeutics Corporation (UTHR) Defined Benefit Plan, Amortization of Gain (Loss)

2.6 / 5 stars · 62/120 Roast Me

United Therapeutics Corporation Defined Benefit Plan, Amortization of Gain (Loss)

United Therapeutics Corporation (UTHR) reported Defined Benefit Plan, Amortization of Gain (Loss) of $1.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses · last filed 2026-02-25

  • United Therapeutics Corporation defined benefit plan, amortization of gain (loss) for fiscal 2025 was $1.30M, a 75.00% decline from fiscal 2024.
  • United Therapeutics Corporation defined benefit plan, amortization of gain (loss) for fiscal 2024 was $5.20M, a 23.81% increase from fiscal 2023.
  • United Therapeutics Corporation defined benefit plan, amortization of gain (loss) for fiscal 2023 was $4.20M.
  • United Therapeutics Corporation defined benefit plan, amortization of gain (loss) for fiscal 2022 was $0.00.
Period endDefined Benefit Plan, Amortization of Gain (Loss) 12 month
2025-12-31$1.30M
10-K · filed 2026-02-25
2024-12-31$5.20M
10-K · filed 2026-02-25
2023-12-31$4.20M
10-K · filed 2026-02-25
2022-12-31$0.00
10-K · filed 2025-02-26
2021-12-31$0.00
10-K · filed 2024-02-21
2020-12-31$0.00
10-K · filed 2022-02-24
2019-12-31$2.20M
10-K · filed 2022-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
Viatris Inc (VTRS)United States$20.008B-0.00
Royalty Pharma plc (RPRX)United States$22.628B
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17